Stenotrophomonas maltophilia Epidemiology, Resistance Characteristics, and Clinical Outcomes: Understanding of the Recent Three Years’ Trends

Stenotrophomonas maltophilia bacteremia in children: risk factors and mortality rate

(2021) Mohammed Alsuhaibani et al.   Antimicrobial Resistance and Infection Control

State-of-the-art review of secondary pulmonary infections in patients with COVID-19 pneumonia

(2021) Woon H. Chong et al.   INFECTION

Increased antimicrobial resistance during the COVID-19 pandemic

(2021) Chih-Cheng Lai et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Stenotrophomonas maltophilia: From trivial to grievous

(2017) Vikas Gautam et al.   Indian Journal of Medical Microbiology

Emergence of Stenotrophomonas maltophilia nosocomial isolates in a Saudi children’s hospital. Risk factors and clinical characteristics

(2017) Jobran Alqahtani   SAUDI MEDICAL JOURNAL

Stenotrophomonas maltophilia as an Emerging Ubiquitous Pathogen: Looking Beyond Contemporary Antibiotic Therapy

(2017) Anthony A. Adegoke et al.   Frontiers in Microbiology

Antibiotics resistance of Stenotrophomonas maltophilia strains isolated from various clinical specimens

(2016) Aytekin Çıkman et al.   African Health Sciences

New strategies againstStenotrophomonas maltophilia: a serious worldwide intrinsically drug-resistant opportunistic pathogen

(2013) Joanna S Brooke   Expert Review of Anti-Infective Therapy

Stenotrophomonas maltophilia: an Emerging Global Opportunistic Pathogen

(2012) J. S. Brooke   CLINICAL MICROBIOLOGY REVIEWS

Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance

(2011) A.-P. Magiorakos et al.   CLINICAL MICROBIOLOGY AND INFECTION

Therapeutic options for Stenotrophomonas maltophilia infections beyond co-trimoxazole: a systematic review

(2008) Matthew E. Falagas et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY